Syncom Formulation (India) Ltd

SYNCOMF

Company Profile

  • Business description

    Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

  • Contact

    207, Saket Nagar
    Near Saket Club
    IndoreMP452018
    IND

    T: +91 7312560458

    https://www.sfil.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    1,324

Stocks News & Analysis

stocks

Are we as bullish on Oracle as the market?

Shares jumped in response to the latest results.
stocks

Anglo American strikes deal to create a new copper giant

We are surprised that Teck agreed to the merger on these terms, and wouldn’t be surprised if there is a twist in the tale.
stocks

The ‘other’ AI chip behemoth that might just be getting started

The magnitude of growth at Broadcom continues to astound us.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,071.409.10-0.10%
CAC 407,823.5262.200.80%
DAX 4023,703.6570.700.30%
Dow JONES (US)46,072.58581.661.28%
FTSE 1009,297.5872.190.78%
HKSE26,086.32113.94-0.43%
NASDAQ22,014.41128.350.59%
Nikkei 22544,372.50534.831.22%
NZX 50 Index13,229.1547.09-0.35%
S&P 5006,580.7548.710.75%
S&P/ASX 2008,805.008.80-0.10%
SSE Composite Index3,875.3163.091.65%

Market Movers